🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,57 USD

Máx. histórico

178,74

2144 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,17%

Rango 52 semanas

14,68 – 24,68

Variación hoy

-7,48%

Cierre anterior

18,99

Rango de hoy

17,44 – 18,92

Volumen hoy

1.859.162

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 16 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
03/12/2019 110,59 113,15 110,01 111,31 +2,33% 2,84% 1.457.100
02/12/2019 112,60 112,92 108,11 108,78 -3,30% 4,27% 1.579.800
29/11/2019 111,02 113,54 110,24 112,49 +1,42% 2,97% 356.200
27/11/2019 108,71 111,39 108,16 110,92 +1,86% 2,97% 721.100
26/11/2019 107,00 109,26 104,84 108,89 +1,68% 4,13% 1.317.400
25/11/2019 108,00 108,70 107,00 107,09 +0,07% 1,57% 1.559.800
22/11/2019 104,20 107,51 103,26 107,02 +2,74% 4,08% 1.397.700
21/11/2019 102,27 105,00 101,21 104,17 +1,83% 3,71% 1.071.400
20/11/2019 98,00 102,80 98,00 102,30 +4,35% 4,90% 1.533.300
19/11/2019 98,29 99,17 96,54 98,04 +0,14% 2,68% 1.132.400
18/11/2019 97,60 98,43 96,21 97,90 +0,45% 2,27% 966.100
15/11/2019 97,93 98,43 96,60 97,46 +0,05% 1,87% 1.083.200
14/11/2019 99,64 100,25 95,79 97,41 -3,55% 4,48% 1.526.300
13/11/2019 98,87 103,44 98,00 101,00 +1,05% 5,50% 2.168.700
12/11/2019 99,29 100,70 96,00 99,95 +5,45% 4,73% 2.845.400
11/11/2019 95,28 96,00 92,00 94,78 -1,56% 4,20% 1.346.000
08/11/2019 91,00 98,78 90,00 96,28 +3,11% 9,65% 2.233.700
07/11/2019 93,23 94,75 92,26 93,38 +1,16% 2,67% 1.281.700
06/11/2019 92,59 94,52 91,60 92,31 -1,27% 3,15% 1.098.700
05/11/2019 91,29 94,49 89,07 93,50 +2,96% 5,94% 1.510.000
04/11/2019 89,42 91,77 88,89 90,81 +2,53% 3,22% 1.287.500
01/11/2019 85,00 88,70 84,42 88,57 +6,63% 5,04% 1.118.700
31/10/2019 83,30 84,20 81,43 83,06 -1,02% 3,33% 707.200
30/10/2019 86,05 86,09 83,55 83,92 -2,99% 2,95% 657.600
29/10/2019 87,95 88,13 86,40 86,51 -1,39% 1,97% 537.200
28/10/2019 85,89 88,68 85,12 87,73 +2,31% 4,14% 1.003.600
25/10/2019 83,81 86,35 82,56 85,75 +2,66% 4,52% 841.600
24/10/2019 84,48 84,63 82,22 83,53 -0,70% 2,85% 717.400
23/10/2019 85,33 86,55 83,69 84,12 -1,67% 3,35% 852.600
22/10/2019 86,80 87,98 85,37 85,55 -1,24% 3,01% 950.200